Blood lipid profiles including triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and glucose were evaluated at baseline and at the end of the 12-week trial by automated enzymatic methods (Cholestech LDX, Hayward, CA, USA) from whole blood.